Literature DB >> 29875320

Wild-type Kras expands and exhausts hematopoietic stem cells.

Joshua P Sasine1,2,3,4, Heather A Himburg1, Christina M Termini1, Martina Roos1,3,4, Evelyn Tran1, Liman Zhao1, Jenny Kan1, Michelle Li1, Yurun Zhang1, Stéphanie C de Barros5, Dinesh S Rao1,3,4,5, Christopher M Counter6, John P Chute1,3,4.   

Abstract

Oncogenic Kras expression specifically in hematopoietic stem cells (HSCs) induces a rapidly fatal myeloproliferative neoplasm in mice, suggesting that Kras signaling plays a dominant role in normal hematopoiesis. However, such a conclusion is based on expression of an oncogenic version of Kras. Hence, we sought to determine the effect of simply increasing the amount of endogenous wild-type Kras on HSC fate. To this end, we utilized a codon-optimized version of the murine Kras gene (Krasex3op) that we developed, in which silent mutations in exon 3 render the encoded mRNA more efficiently translated, leading to increased protein expression without disruption to the normal gene architecture. We found that Kras protein levels were significantly increased in bone marrow (BM) HSCs in Krasex3op/ex3op mice, demonstrating that the translation of Kras in HSCs is normally constrained by rare codons. Krasex3op/ex3op mice displayed expansion of BM HSCs, progenitor cells, and B lymphocytes, but no evidence of myeloproliferative disease or leukemia in mice followed for 12 months. BM HSCs from Krasex3op/ex3op mice demonstrated increased multilineage repopulating capacity in primary competitive transplantation assays, but secondary competitive transplants revealed exhaustion of long-term HSCs. Following total body irradiation, Krasex3op/ex3op mice displayed accelerated hematologic recovery and increased survival. Mechanistically, HSCs from Krasex3op/ex3op mice demonstrated increased proliferation at baseline, with a corresponding increase in Erk1/2 phosphorylation and cyclin-dependent kinase 4 and 6 (Cdk4/6) activation. Furthermore, both the enhanced colony-forming capacity and in vivo repopulating capacity of HSCs from Krasex3op/ex3op mice were dependent on Cdk4/6 activation. Finally, BM transplantation studies revealed that augmented Kras expression produced expansion of HSCs, progenitor cells, and B cells in a hematopoietic cell-autonomous manner, independent from effects on the BM microenvironment. This study provides fundamental demonstration of codon usage in a mammal having a biological consequence, which may speak to the importance of codon usage in mammalian biology.

Entities:  

Keywords:  Hematology; Hematopoietic stem cells; Stem cells

Mesh:

Substances:

Year:  2018        PMID: 29875320      PMCID: PMC6124423          DOI: 10.1172/jci.insight.98197

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  58 in total

1.  Codon usage tabulated from international DNA sequence databases: status for the year 2000.

Authors:  Y Nakamura; T Gojobori; T Ikemura
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning.

Authors:  Junya Kanda; David A Rizzieri; Cristina Gasparetto; Gwynn D Long; John P Chute; Keith M Sullivan; Ashley Morris; Clayton A Smith; Donna E Hogge; Janet Nitta; Kevin Song; Donna Niedzwiecki; Nelson J Chao; Mitchell E Horwitz
Journal:  Biol Blood Marrow Transplant       Date:  2010-09-22       Impact factor: 5.742

3.  Mice expressing KrasG12D in hematopoietic multipotent progenitor cells develop neonatal myeloid leukemia.

Authors:  Stefan P Tarnawsky; Michihiro Kobayashi; Rebecca J Chan; Mervin C Yoder
Journal:  J Clin Invest       Date:  2017-08-28       Impact factor: 14.808

4.  Rare codons capacitate Kras-driven de novo tumorigenesis.

Authors:  Nicole L K Pershing; Benjamin L Lampson; Jason A Belsky; Erin Kaltenbrun; David M MacAlpine; Christopher M Counter
Journal:  J Clin Invest       Date:  2014-12-01       Impact factor: 14.808

5.  Deletion of the Imprinted Gene Grb10 Promotes Hematopoietic Stem Cell Self-Renewal and Regeneration.

Authors:  Xiao Yan; Heather A Himburg; Katherine Pohl; Mamle Quarmyne; Evelyn Tran; Yurun Zhang; Tiancheng Fang; Jenny Kan; Nelson J Chao; Liman Zhao; Phuong L Doan; John P Chute
Journal:  Cell Rep       Date:  2016-11-01       Impact factor: 9.423

6.  Mutant N-ras induces myeloproliferative disorders and apoptosis in bone marrow repopulated mice.

Authors:  K L MacKenzie; A Dolnikov; M Millington; Y Shounan; G Symonds
Journal:  Blood       Date:  1999-03-15       Impact factor: 22.113

7.  Modulation of hematopoietic stem cell homing and engraftment by CD26.

Authors:  Kent W Christopherson; Giao Hangoc; Charlie R Mantel; Hal E Broxmeyer
Journal:  Science       Date:  2004-08-13       Impact factor: 47.728

8.  Hematopoietic cell fate and the initiation of leukemic properties in primitive primary human cells are influenced by Ras activity and farnesyltransferase inhibition.

Authors:  Craig Dorrell; Katsuto Takenaka; Mark D Minden; Robert G Hawley; John E Dick
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

9.  Hoxb5 marks long-term haematopoietic stem cells and reveals a homogenous perivascular niche.

Authors:  James Y Chen; Masanori Miyanishi; Sean K Wang; Satoshi Yamazaki; Rahul Sinha; Kevin S Kao; Jun Seita; Debashis Sahoo; Hiromitsu Nakauchi; Irving L Weissman
Journal:  Nature       Date:  2016-02-11       Impact factor: 49.962

10.  Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance.

Authors:  Moiez Ali; Erin Kaltenbrun; Gray R Anderson; Sarah Jo Stephens; Sabrina Arena; Alberto Bardelli; Christopher M Counter; Kris C Wood
Journal:  Nat Commun       Date:  2017-06-08       Impact factor: 14.919

View more
  8 in total

1.  Genetically manipulating endogenous Kras levels and oncogenic mutations in vivo influences tissue patterning of murine tumorigenesis.

Authors:  Özgün Le Roux; Nicole L K Pershing; Erin Kaltenbrun; Nicole J Newman; Jeffrey I Everitt; Elisa Baldelli; Mariaelena Pierobon; Emanuel F Petricoin; Christopher M Counter
Journal:  Elife       Date:  2022-09-07       Impact factor: 8.713

2.  Codon usage regulates human KRAS expression at both transcriptional and translational levels.

Authors:  Jingjing Fu; Yunkun Dang; Christopher Counter; Yi Liu
Journal:  J Biol Chem       Date:  2018-10-01       Impact factor: 5.157

3.  Noncoding Variants Connect Enhancer Dysregulation with Nuclear Receptor Signaling in Hematopoietic Malignancies.

Authors:  Kailong Li; Yuannyu Zhang; Xin Liu; Yuxuan Liu; Zhimin Gu; Hui Cao; Kathryn E Dickerson; Mingyi Chen; Weina Chen; Zhen Shao; Min Ni; Jian Xu
Journal:  Cancer Discov       Date:  2020-03-18       Impact factor: 39.397

4.  Nuclear DEK preserves hematopoietic stem cells potential via NCoR1/HDAC3-Akt1/2-mTOR axis.

Authors:  Zhe Chen; Dawei Huo; Lei Li; Zhilong Liu; Zhigang Li; Shuangnian Xu; Yongxiu Huang; Weiru Wu; Chengfang Zhou; Yuanyuan Liu; Mei Kuang; Feng Wu; Hui Li; Pengxu Qian; Guanbin Song; Xudong Wu; Jieping Chen; Yu Hou
Journal:  J Exp Med       Date:  2021-05-03       Impact factor: 14.307

5.  CITED2 coordinates key hematopoietic regulatory pathways to maintain the HSC pool in both steady-state hematopoiesis and transplantation.

Authors:  Hannah Lawson; Louie N van de Lagemaat; Melania Barile; Andrea Tavosanis; Jozef Durko; Arnaud Villacreces; Aarushi Bellani; Christopher Mapperley; Elise Georges; Catarina Martins-Costa; Catarina Sepulveda; Lewis Allen; Joana Campos; Kirsteen J Campbell; Dónal O'Carroll; Berthold Göttgens; Suzanne Cory; Neil P Rodrigues; Amelie V Guitart; Kamil R Kranc
Journal:  Stem Cell Reports       Date:  2021-10-28       Impact factor: 7.765

6.  Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia.

Authors:  Alejandro M Hortal; Clara L Oeste; Claudia Cifuentes; Miguel Alcoceba; Isabel Fernández-Pisonero; Laura Clavaín; Rut Tercero; Pilar Mendoza; Verónica Domínguez; Marta García-Flores; Belén Pintado; David Abia; Carmen García-Macías; Almudena Navarro-Bailón; Xosé R Bustelo; Marcos González; Balbino Alarcón
Journal:  Mol Cancer       Date:  2022-02-04       Impact factor: 27.401

Review 7.  Advances in molecular characterization of myeloid proliferations associated with Down syndrome.

Authors:  Jixia Li; Maggie L Kalev-Zylinska
Journal:  Front Genet       Date:  2022-08-10       Impact factor: 4.772

8.  Meta-Analysis of Human and Mouse Biliary Epithelial Cell Gene Profiles.

Authors:  Stefaan Verhulst; Tania Roskams; Pau Sancho-Bru; Leo A van Grunsven
Journal:  Cells       Date:  2019-09-20       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.